France: OSE Immunotherapeutics enters a loan agreement of up to €25 million with the EIB
©ShutterstockThis loan will further support the progress and expansion of OSE Immunotherapeutics’ lead clinical development programs in diseases with high unmet medical needs, Divided into three tranches including two tranches of €10 million each and a… read more